chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia
Clinical narrative: pain in my shoulder; This is a spontaneous report from a contactable consumer (Patient). A 73-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EW0150; Expiration Date: 27Sep2021), via an unspecified route of administration on 14Apr2021 (at the age of 73-year-old) as 1st dose, single for covid-19 immunisation.The medical history included blood pressure medication. Concomitant medication included lisinopril taken for blood pressure medication and thyroid medication. On 16Apr2021 patient experienced pain in shoulder. Consumer stated that she took Lisinopril, and it said a blood pressure medication and the thyroid medication, the both low. She just wondering how long this condition is going to lasts and exactly why, she believe that the Nurse who gave me the shot, put the it high on the shoulder towards the back of her shoulder and so if I try to see the bandage and she looked back and can't see the bandage. The 3rd day after she received the shot, she started having pain in shoulder to the point when she had to use the medication in order to get rid of it. So, she wanted and she did, well She went to her family doctor last week. Doctor felt that it does not related to the vaccine and she gave her exercises to do. The Patient stated that her concern is, was this damage to a ligament or a nerve or something to the shoulder capsule and why she was having for this long a period of time. Reported No Seriousness. The patient received treatment Tylenol (500mg), using ice, a heating pad, using topical such as Bio-freeze and Salonpas. "Consumer stated, "Well, it's better over two weeks, since she got her shot. So, it's a matter of 2 weeks now. So, she guess yes. Persisting.". The outcome for the event was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Hyperhidrosis, Malaise, Tremor
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Disorientation, Diverticulitis, Dizziness, Headache, Tinnitus
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urinary tract infection
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Disorientation, Diverticulitis, Dizziness, Dysgeusia
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Fear, Feeling abnormal, Headache, Hypothyroidism
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Infection, Influenza like illness, Lethargy, Malaise, Speech disorder
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thirst, Visual impairment, White blood cell count, White blood cells urine positive
Clinical narrative: Immediate reaction, dizziness, ringing in ears, headache, disoriented, taken to ER, was not treated
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: CONFIRMED COVID-19 INFECTION; DEATH; This spontaneous report received from a health care professional concerned a 90 year old. The patient's height, and weight were not reported. The patient had medical history but was not provided. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 30-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient was a home bound patient. On 05-Apr-2021, the patient was tested positive for Covid-19 using PCR test, and was hospitalized (date unspecified). On 01-May-2021, he passed away and cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was serious (Death and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: The suspected product quality complaint has been confirmed to be voided. No PQC was identified within the reported complaint reported. based on the PQC evaluation/investigation performed.; Sender's Comments: V0 20210642414-COVID-19 VACCINE AD26.COV2.S-Death and confirmed covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Death, Decreased appetite, Decreased eye contact, Delusion
Clinical narrative: CONFIRMED COVID-19 INFECTION; DEATH; This spontaneous report received from a health care professional concerned a 90 year old. The patient's height, and weight were not reported. The patient had medical history but was not provided. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 30-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient was a home bound patient. On 05-Apr-2021, the patient was tested positive for Covid-19 using PCR test, and was hospitalized (date unspecified). On 01-May-2021, he passed away and cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was serious (Death and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: The suspected product quality complaint has been confirmed to be voided. No PQC was identified within the reported complaint reported. based on the PQC evaluation/investigation performed.; Sender's Comments: V0 20210642414-COVID-19 VACCINE AD26.COV2.S-Death and confirmed covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diabetes mellitus, Dysarthria, Dyspnoea, Dysstasia, Exposure to SARS-CoV-2
Clinical narrative: CONFIRMED COVID-19 INFECTION; DEATH; This spontaneous report received from a health care professional concerned a 90 year old. The patient's height, and weight were not reported. The patient had medical history but was not provided. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 30-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient was a home bound patient. On 05-Apr-2021, the patient was tested positive for Covid-19 using PCR test, and was hospitalized (date unspecified). On 01-May-2021, he passed away and cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was serious (Death and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: The suspected product quality complaint has been confirmed to be voided. No PQC was identified within the reported complaint reported. based on the PQC evaluation/investigation performed.; Sender's Comments: V0 20210642414-COVID-19 VACCINE AD26.COV2.S-Death and confirmed covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fall, Feeling abnormal, Hypertension, Mental disorder, Posture abnormal
Clinical narrative: CONFIRMED COVID-19 INFECTION; DEATH; This spontaneous report received from a health care professional concerned a 90 year old. The patient's height, and weight were not reported. The patient had medical history but was not provided. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 30-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient was a home bound patient. On 05-Apr-2021, the patient was tested positive for Covid-19 using PCR test, and was hospitalized (date unspecified). On 01-May-2021, he passed away and cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was serious (Death and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: The suspected product quality complaint has been confirmed to be voided. No PQC was identified within the reported complaint reported. based on the PQC evaluation/investigation performed.; Sender's Comments: V0 20210642414-COVID-19 VACCINE AD26.COV2.S-Death and confirmed covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Prostate cancer, Respiratory failure, SARS-CoV-2 test positive, Tremor, Vision blurred
Clinical narrative: CONFIRMED COVID-19 INFECTION; DEATH; This spontaneous report received from a health care professional concerned a 90 year old. The patient's height, and weight were not reported. The patient had medical history but was not provided. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 30-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient was a home bound patient. On 05-Apr-2021, the patient was tested positive for Covid-19 using PCR test, and was hospitalized (date unspecified). On 01-May-2021, he passed away and cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was serious (Death and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: The suspected product quality complaint has been confirmed to be voided. No PQC was identified within the reported complaint reported. based on the PQC evaluation/investigation performed.; Sender's Comments: V0 20210642414-COVID-19 VACCINE AD26.COV2.S-Death and confirmed covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test
Clinical narrative: CONFIRMED COVID-19 INFECTION; DEATH; This spontaneous report received from a health care professional concerned a 90 year old. The patient's height, and weight were not reported. The patient had medical history but was not provided. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 30-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient was a home bound patient. On 05-Apr-2021, the patient was tested positive for Covid-19 using PCR test, and was hospitalized (date unspecified). On 01-May-2021, he passed away and cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was serious (Death and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: The suspected product quality complaint has been confirmed to be voided. No PQC was identified within the reported complaint reported. based on the PQC evaluation/investigation performed.; Sender's Comments: V0 20210642414-COVID-19 VACCINE AD26.COV2.S-Death and confirmed covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Cervical spinal stenosis, Discomfort, Feeling abnormal, Gingival discomfort, Hypoaesthesia
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Illness, Influenza like illness, Lagophthalmos, Magnetic resonance imaging, Mobility decreased
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Nerve compression, Neuritis, Oral discomfort, Paraesthesia oral
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Restlessness, Salivary hypersecretion, Stress
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Cervical spinal stenosis, Computerised tomogram, Feeling abnormal, Herpes zoster, Limb discomfort
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Neuritis, Paraesthesia, Paraesthesia oral, Stress
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: X-ray
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, VARZOS, COVID19, COVID19
Symptoms: Glossitis, Stomatitis
Clinical narrative: mouth, cheek and tongue felt irritated; mouth, cheek and tongue felt irritated; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration on 07Mar2021 as 2nd dose, single for COVID-19 immunisation. Medical history included had shingles back in Oct2019 and had it on his left ear, left side of face to an unknown date, bell's palsy, facial paralysis, vertigo and went through physical therapy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, the reporter states that after 2nd dose mouth, cheek and tongue felt irritated. reporter has called before and filled out the forms and sent them back to Drug and Safety. Reporter wanting to know if scientists have thought about how 1 virus affects another virus with having the covid-19 vaccine. Reporter wondering if he reacted because still not completely over effects of having shingles. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Death  5/27/2021 Causes of death listed on death certificate: 1. acute hypoxic respiratory failure  2. covid 19 pneumonia  3. covid 19 infection  4. COPD, CHF, squamous cell carcinoma of the lung
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Chronic obstructive pulmonary disease
Clinical narrative: Death  5/27/2021 Causes of death listed on death certificate: 1. acute hypoxic respiratory failure  2. covid 19 pneumonia  3. covid 19 infection  4. COPD, CHF, squamous cell carcinoma of the lung
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Death, Nucleic acid test, SARS-CoV-2 test positive, Squamous cell carcinoma of lung
Clinical narrative: Death  5/27/2021 Causes of death listed on death certificate: 1. acute hypoxic respiratory failure  2. covid 19 pneumonia  3. covid 19 infection  4. COPD, CHF, squamous cell carcinoma of the lung
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Hypoaesthesia, Peripheral swelling
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pulmonary thrombosis, SARS-CoV-2 test, Ultrasound scan
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, Electrocardiogram, Full blood count, Hypertension, Lacrimation increased
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Ultrasound scan, Vision blurred
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, Electrocardiogram, Fatigue, Hypoaesthesia, Peripheral swelling
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pulmonary thrombosis, SARS-CoV-2 test, Somnolence, Ultrasound scan
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Computerised tomogram, Electrocardiogram, Heart rate, Hypoaesthesia
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Pulmonary thrombosis, SARS-CoV-2 test, Thrombosis, Ultrasound scan
Clinical narrative: swelling of extremities, legs and feet and toes were swollen badly . eyes were blurry and constantly watering.  hbp
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electromyogram abnormal, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Intensive care
Clinical narrative: Pt started with headaches sinus pain. Was treated at her family doctor for a sinus infection. These symptoms did not go away and on 5/7/2021 she started getting tingling and numbness in her hands and feet. On 5/8/2021 she was taken to the Hospital and blood work and MRI was taken but did not see anything. She was told to follow up with her family physician on Monday 5/10/2021. She got worse in the evening and had trouble walking. She was taken to another hospital at 4:00 A M on 5/9/2021. On 5/9/2021 the neurologist thought she may have a chemical imbalance. After getting and MRI, blood work and and EMG on 5/10/2021 she was diagnosed with Gillian Barre syndrome and treatments
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mechanical ventilation, Muscular weakness, Paraesthesia
Clinical narrative: Pt started with headaches sinus pain. Was treated at her family doctor for a sinus infection. These symptoms did not go away and on 5/7/2021 she started getting tingling and numbness in her hands and feet. On 5/8/2021 she was taken to the Hospital and blood work and MRI was taken but did not see anything. She was told to follow up with her family physician on Monday 5/10/2021. She got worse in the evening and had trouble walking. She was taken to another hospital at 4:00 A M on 5/9/2021. On 5/9/2021 the neurologist thought she may have a chemical imbalance. After getting and MRI, blood work and and EMG on 5/10/2021 she was diagnosed with Gillian Barre syndrome and treatments
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Electromyogram, Gait disturbance
Clinical narrative: Pt started with headaches sinus pain. Was treated at her family doctor for a sinus infection. These symptoms did not go away and on 5/7/2021 she started getting tingling and numbness in her hands and feet. On 5/8/2021 she was taken to the Hospital and blood work and MRI was taken but did not see anything. She was told to follow up with her family physician on Monday 5/10/2021. She got worse in the evening and had trouble walking. She was taken to another hospital at 4:00 A M on 5/9/2021. On 5/9/2021 the neurologist thought she may have a chemical imbalance. After getting and MRI, blood work and and EMG on 5/10/2021 she was diagnosed with Gillian Barre syndrome and treatments
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Headache, Hypoaesthesia, Magnetic resonance imaging, Paraesthesia
Clinical narrative: Pt started with headaches sinus pain. Was treated at her family doctor for a sinus infection. These symptoms did not go away and on 5/7/2021 she started getting tingling and numbness in her hands and feet. On 5/8/2021 she was taken to the Hospital and blood work and MRI was taken but did not see anything. She was told to follow up with her family physician on Monday 5/10/2021. She got worse in the evening and had trouble walking. She was taken to another hospital at 4:00 A M on 5/9/2021. On 5/9/2021 the neurologist thought she may have a chemical imbalance. After getting and MRI, blood work and and EMG on 5/10/2021 she was diagnosed with Gillian Barre syndrome and treatments
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sinus pain, Sinusitis
Clinical narrative: Pt started with headaches sinus pain. Was treated at her family doctor for a sinus infection. These symptoms did not go away and on 5/7/2021 she started getting tingling and numbness in her hands and feet. On 5/8/2021 she was taken to the Hospital and blood work and MRI was taken but did not see anything. She was told to follow up with her family physician on Monday 5/10/2021. She got worse in the evening and had trouble walking. She was taken to another hospital at 4:00 A M on 5/9/2021. On 5/9/2021 the neurologist thought she may have a chemical imbalance. After getting and MRI, blood work and and EMG on 5/10/2021 she was diagnosed with Gillian Barre syndrome and treatments
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Computerised tomogram, Thrombosis, Ultrasound scan
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161), via an unspecified route of administration on 19Apr2021 (at the age of 66-years-old) as dose 2, single for COVID-19 immunization. The vaccine was administered at the Pharmacy/drugstore. The patient medical history included restless legs from an unknown date. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. The patient does not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included pramipexole; and amitriptyline hydrochloride (AMITRIPTYLIN) both were taken for an unspecified indication, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6204) on 22Mar2021 (at the age of 66-years-old) as dose 1, single for COVID-19 immunization. It was reported that the patient started noticing shortness of breath 2 weeks after second vaccine (reported as 07May2021), then noted his heart rate was 120. He went to family doctor, his EKG was abnormal, then went to hospital. CT showed multiple pulmonary clots and some massive, they noted extensive clot in right leg. He was then admitted to ICU. Have no history or underlying cause for clots, no travel related. The doctors felt highly related to vaccine . The doctor stated likely to never be back to level of health before vaccine. The patient was hospitalized due to the reported events from 07May2021 to 11May2021. The reported events were considered life-threatening and disabling. Therapeutic measures were taken as a result of the reported events as the patient received blood thinners. The reported events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the events was recovered with sequel on an unspecified date in 2021. Since the vaccination, the patient has not been tested for COVID-19.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Dyspnoea, Electrocardiogram, Electrocardiogram abnormal, Heart rate
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161), via an unspecified route of administration on 19Apr2021 (at the age of 66-years-old) as dose 2, single for COVID-19 immunization. The vaccine was administered at the Pharmacy/drugstore. The patient medical history included restless legs from an unknown date. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. The patient does not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included pramipexole; and amitriptyline hydrochloride (AMITRIPTYLIN) both were taken for an unspecified indication, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6204) on 22Mar2021 (at the age of 66-years-old) as dose 1, single for COVID-19 immunization. It was reported that the patient started noticing shortness of breath 2 weeks after second vaccine (reported as 07May2021), then noted his heart rate was 120. He went to family doctor, his EKG was abnormal, then went to hospital. CT showed multiple pulmonary clots and some massive, they noted extensive clot in right leg. He was then admitted to ICU. Have no history or underlying cause for clots, no travel related. The doctors felt highly related to vaccine . The doctor stated likely to never be back to level of health before vaccine. The patient was hospitalized due to the reported events from 07May2021 to 11May2021. The reported events were considered life-threatening and disabling. Therapeutic measures were taken as a result of the reported events as the patient received blood thinners. The reported events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the events was recovered with sequel on an unspecified date in 2021. Since the vaccination, the patient has not been tested for COVID-19.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Pulmonary thrombosis, Thrombosis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161), via an unspecified route of administration on 19Apr2021 (at the age of 66-years-old) as dose 2, single for COVID-19 immunization. The vaccine was administered at the Pharmacy/drugstore. The patient medical history included restless legs from an unknown date. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. The patient does not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included pramipexole; and amitriptyline hydrochloride (AMITRIPTYLIN) both were taken for an unspecified indication, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6204) on 22Mar2021 (at the age of 66-years-old) as dose 1, single for COVID-19 immunization. It was reported that the patient started noticing shortness of breath 2 weeks after second vaccine (reported as 07May2021), then noted his heart rate was 120. He went to family doctor, his EKG was abnormal, then went to hospital. CT showed multiple pulmonary clots and some massive, they noted extensive clot in right leg. He was then admitted to ICU. Have no history or underlying cause for clots, no travel related. The doctors felt highly related to vaccine . The doctor stated likely to never be back to level of health before vaccine. The patient was hospitalized due to the reported events from 07May2021 to 11May2021. The reported events were considered life-threatening and disabling. Therapeutic measures were taken as a result of the reported events as the patient received blood thinners. The reported events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of the events was recovered with sequel on an unspecified date in 2021. Since the vaccination, the patient has not been tested for COVID-19.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: The decedent is an 83 year-old woman with history of hypertension, hyperlipidemia, hypothyroidism, and SIADH (syndrome of inappropriate antidiuretic hormone secretion).  She was a former smoker and her past surgical history includes treatment for varicose veins.  Per the off campus request form her medical history also includes congestive heart failure, atrial fibrillation, seasonal allergies, and allergic reactions to multiple medications, right lower leg ulcer, and generalized decreased energy and chills following Moderna COVID vaccine received at Medical Center (first dose was on 04/22/2021 and final dose was on 05/20/2021).  A clinical note from 03/05/2021 at Medical Center also indicates that she had fevers and chills at that time, possibly due to left lower extremity cellulitis. She was last seen alive in bed around 4:00 on 05/26/2021 by her son who spoke to her as he left for work.  He returned home around 16:30 and found her unresponsive on the living room floor, 911 was called.  Date and time of death was 05/26/2021 at 16:13.     The family requested an autopsy to assess whether the vaccine could have contributed to the death.  Autopsy was notable for hypertensive and atherosclerotic cardiovascular disease which was the likely cause of death.  However, autopsy also revealed and acute and organizing fibrinous pericarditis, of uncertain etiology, possibly vaccine-related.    No cause of the pericarditis was apparent at autopsy.  No evidence of recent myocardial infarction.  Postmortem tryptase was also elevated (57 ng/ml).    This case is being reported to VAERS as a possible case of Moderna vaccine-associated pericarditis in an elderly person.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arteriosclerosis, Autopsy, Death, Hypertensive heart disease, Pericarditis
Clinical narrative: The decedent is an 83 year-old woman with history of hypertension, hyperlipidemia, hypothyroidism, and SIADH (syndrome of inappropriate antidiuretic hormone secretion).  She was a former smoker and her past surgical history includes treatment for varicose veins.  Per the off campus request form her medical history also includes congestive heart failure, atrial fibrillation, seasonal allergies, and allergic reactions to multiple medications, right lower leg ulcer, and generalized decreased energy and chills following Moderna COVID vaccine received at Medical Center (first dose was on 04/22/2021 and final dose was on 05/20/2021).  A clinical note from 03/05/2021 at Medical Center also indicates that she had fevers and chills at that time, possibly due to left lower extremity cellulitis. She was last seen alive in bed around 4:00 on 05/26/2021 by her son who spoke to her as he left for work.  He returned home around 16:30 and found her unresponsive on the living room floor, 911 was called.  Date and time of death was 05/26/2021 at 16:13.     The family requested an autopsy to assess whether the vaccine could have contributed to the death.  Autopsy was notable for hypertensive and atherosclerotic cardiovascular disease which was the likely cause of death.  However, autopsy also revealed and acute and organizing fibrinous pericarditis, of uncertain etiology, possibly vaccine-related.    No cause of the pericarditis was apparent at autopsy.  No evidence of recent myocardial infarction.  Postmortem tryptase was also elevated (57 ng/ml).    This case is being reported to VAERS as a possible case of Moderna vaccine-associated pericarditis in an elderly person.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tryptase increased, Unresponsive to stimuli
Clinical narrative: The decedent is an 83 year-old woman with history of hypertension, hyperlipidemia, hypothyroidism, and SIADH (syndrome of inappropriate antidiuretic hormone secretion).  She was a former smoker and her past surgical history includes treatment for varicose veins.  Per the off campus request form her medical history also includes congestive heart failure, atrial fibrillation, seasonal allergies, and allergic reactions to multiple medications, right lower leg ulcer, and generalized decreased energy and chills following Moderna COVID vaccine received at Medical Center (first dose was on 04/22/2021 and final dose was on 05/20/2021).  A clinical note from 03/05/2021 at Medical Center also indicates that she had fevers and chills at that time, possibly due to left lower extremity cellulitis. She was last seen alive in bed around 4:00 on 05/26/2021 by her son who spoke to her as he left for work.  He returned home around 16:30 and found her unresponsive on the living room floor, 911 was called.  Date and time of death was 05/26/2021 at 16:13.     The family requested an autopsy to assess whether the vaccine could have contributed to the death.  Autopsy was notable for hypertensive and atherosclerotic cardiovascular disease which was the likely cause of death.  However, autopsy also revealed and acute and organizing fibrinous pericarditis, of uncertain etiology, possibly vaccine-related.    No cause of the pericarditis was apparent at autopsy.  No evidence of recent myocardial infarction.  Postmortem tryptase was also elevated (57 ng/ml).    This case is being reported to VAERS as a possible case of Moderna vaccine-associated pericarditis in an elderly person.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Body temperature, Fatigue, Fibrin D dimer, Full blood count
Clinical narrative: I got really tired after the second shot. A lot of fatigue everyday. Joint pain all over the body.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza like illness, Oxygen saturation, Pyrexia, Thyroid function test, Urine analysis
Clinical narrative: I got really tired after the second shot. A lot of fatigue everyday. Joint pain all over the body.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood test, Fatigue
Clinical narrative: I got really tired after the second shot. A lot of fatigue everyday. Joint pain all over the body.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injected limb mobility decreased, Injection site pain, Injection site paraesthesia, Shoulder injury related to vaccine administration
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site pain
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Arthropathy, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Ear pain, Facial paralysis, Vision blurred
Clinical narrative: 3 days after vaccine work up with unilateral facial paralysis
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Computerised tomogram head, Cough, Decreased appetite, Facial paralysis
Clinical narrative: 3 days after vaccine work up with unilateral facial paralysis
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: 3 days after vaccine work up with unilateral facial paralysis
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Illness
Clinical narrative: still has throbbing in her arm; feels like there's a ball in her arm; pain is so bad that it wakes her up at night per the caller; This is a spontaneous report from a contactable consumer or other non hcp. A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm on 21May2021 (at the age of 74 years old), as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Previously the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation and experienced feeling sick, loss of appetite, low energy levels, high blood pressure, and fever. The patient experienced still has throbbing in her arm, feels like there's a ball in her arm and pain is so bad that it wakes her up at night per the caller on an unspecified date. The patient reports that she does not have her energy back yet; appetite is coming back. After she had her 2nd dose of the vaccine on 21May2021 and starting last week Monday or Tuesday that patient started to have the complaints of throbbing during the day and night and felt like there's a ball in her left upper arm where shot was administered. Has been putting ice on her shoulder and the pain is so bad that it wakes her up at night. The patient would like to know if her complaints with her left upper extremity is normal and if it is going away. The outcome of the events was unknown.  Information about batch/lot number has been requested.